These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23726864)

  • 1. Validation of a HTS-amenable assay to detect drug-induced mitochondrial toxicity in the absence and presence of cell death.
    Swiss R; Niles A; Cali JJ; Nadanaciva S; Will Y
    Toxicol In Vitro; 2013 Sep; 27(6):1789-97. PubMed ID: 23726864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput dual parameter assay for assessing drug-induced mitochondrial dysfunction provides additional predictivity over two established mitochondrial toxicity assays.
    Hynes J; Nadanaciva S; Swiss R; Carey C; Kirwan S; Will Y
    Toxicol In Vitro; 2013 Mar; 27(2):560-9. PubMed ID: 23147640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial membrane potential measurement of H9c2 cells grown in high-glucose and galactose-containing media does not provide additional predictivity towards mitochondrial assessment.
    Rana P; Nadanaciva S; Will Y
    Toxicol In Vitro; 2011 Mar; 25(2):580-7. PubMed ID: 21126567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined in vitro approach to improve the prediction of mitochondrial toxicants.
    Eakins J; Bauch C; Woodhouse H; Park B; Bevan S; Dilworth C; Walker P
    Toxicol In Vitro; 2016 Aug; 34():161-170. PubMed ID: 27083147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute extracellular flux (XF) assay to assess compound effects on mitochondrial function.
    Wang R; Novick SJ; Mangum JB; Queen K; Ferrick DA; Rogers GW; Stimmel JB
    J Biomol Screen; 2015 Mar; 20(3):422-9. PubMed ID: 25381255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants.
    Marroquin LD; Hynes J; Dykens JA; Jamieson JD; Will Y
    Toxicol Sci; 2007 Jun; 97(2):539-47. PubMed ID: 17361016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of 109 reference compounds on rat H4IIE and human HepG2 hepatocytes. III: Mechanistic assays on oxygen consumption with MitoXpress and NAD(P)H production with Alamar Blue™.
    Schoonen WG; Stevenson JC; Westerink WM; Horbach GJ
    Toxicol In Vitro; 2012 Apr; 26(3):511-25. PubMed ID: 22261204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A miniaturized homogenous assay of mitochondrial membrane potential.
    Vongs A; Solly KJ; Kiss L; Macneil DJ; Rosenblum CI
    Assay Drug Dev Technol; 2011 Aug; 9(4):373-81. PubMed ID: 21294696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of high-throughput screening techniques to evaluate mitochondrial toxicity.
    Wills LP
    Toxicology; 2017 Nov; 391():34-41. PubMed ID: 28789971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants.
    Delp J; Funke M; Rudolf F; Cediel A; Bennekou SH; van der Stel W; Carta G; Jennings P; Toma C; Gardner I; van de Water B; Forsby A; Leist M
    Arch Toxicol; 2019 Jun; 93(6):1585-1608. PubMed ID: 31190196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of ToxCast Phase II for Mitochondrial Liabilities Using a High-Throughput Respirometric Assay.
    Wills LP; Beeson GC; Hoover DB; Schnellmann RG; Beeson CC
    Toxicol Sci; 2015 Aug; 146(2):226-34. PubMed ID: 25926417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid mitochondrial toxicity assay utilizing rapidly changing cell energy metabolism.
    Sanuki Y; Araki T; Nakazono O; Tsurui K
    J Toxicol Sci; 2017; 42(3):349-358. PubMed ID: 28496041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MitoToxy assay: A novel cell-based method for the assessment of metabolic toxicity in a multiwell plate format using a lactate FRET nanosensor, Laconic.
    Contreras-Baeza Y; Ceballo S; Arce-Molina R; Sandoval PY; Alegría K; Barros LF; San Martín A
    PLoS One; 2019; 14(10):e0224527. PubMed ID: 31671132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of adipose-derived stem cells in high-throughput screening to identify modulators of lipogenesis.
    Lea-Currie YR; Duffin DJ; Buehrer BM
    Methods Mol Biol; 2011; 702():359-68. PubMed ID: 21082415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
    Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
    Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of mitochondrial toxicity in HepG2 cells cultured in high-glucose- or galactose-containing media.
    Swiss R; Will Y
    Curr Protoc Toxicol; 2011 Aug; Chapter 2():Unit2.20. PubMed ID: 21818751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.
    Rana P; Anson B; Engle S; Will Y
    Toxicol Sci; 2012 Nov; 130(1):117-31. PubMed ID: 22843568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.